Medrobotics Corporation logo — company profile

Medrobotics Corporation

Founded 2005 26 employees Debt Financing Total: $206.50M Biotechnology, Hardware +2

General Information

Company Name Medrobotics Corporation
Founded Year 2005
Founders / Decision Makers
Team member Team member Team member
Employees 26
Industries Biotechnology, Hardware, Health Care +1
Funding Stage Debt Financing
Social

Get notified when Medrobotics Corporation moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Medrobotics Corporation

Medrobotics Corporation specializes in manufacturing and marketing the Flex® Robotic System, which is the world's first endoluminal robotic platform with a steerable and shapeable robotic scope. The system offers clinicians the unique ability to navigate complex anatomy with crystal clear 3D HD visualization through a single entry point. It provides a stable platform through which articulating flexible instruments are introduced, allowing consistent triangulation in hard-to-reach anatomical locations. This addresses areas that might otherwise be inaccessible with traditional surgical instruments. The company's vision is to provide more patients with access to endoluminal treatment options. Medrobotics received FDA clearances for the Flex® Robotic System for ENT applications in July 2015 and for transanal applications in May 2017. The CE mark was issued in March 2014. The last investment for the company was a $25.00M Debt Financing investment on 14 June 2018, and the investor was Western Technology Investment. The company operates in the industries of Biotechnology, Hardware, Health Care, and Robotics. Founded in 2005, Medrobotics Corporation is making significant strides in improving endoluminal treatment options for a wide range of patients.

Taxonomy: medical robotics, endoluminal robotic platform, robotic surgery, 3D HD visualization, ENT applications, transanal applications, CE mark, surgical instruments, FDA clearance

Funding Rounds & Investors (14)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• 1
Investor
14 Jun 2018
Series H •••••• - 26 Jan 2017
Series G •••••• 2
Investor
•••• ••••
07 Nov 2015
Series F •••••• - 21 Oct 2014
Series E •••••• 1
Investor
14 May 2014

View All 14 Funding Rounds

Medrobotics Corporation Alternatives & Competitors

Medrobotics Corporation vs
EndoQuest Robotics
EndoQuest Robotics United States

Making endoluminal, scar-free surgery a reality

Series D
76 employees
Medrobotics Corporation vs

Mobile robots solutions for security and defense

1 employees
Medrobotics Corporation vs

Advancing robotic technology for soft tissue open surgery at the micro level

Series C
320 employees
Health Care, Medical Devices

FAQ About Medrobotics Corporation

Medrobotics manufactures and markets the Flex® Robotic System, the world’s first endoluminal robotic platform with a steerable and shapeable robotic scope. The Flex® Robotic System offers clinicians the unique ability to navigate complex anatomy with crystal clear 3D HD visualization through a sin...
Medrobotics Corporation was founded in 2005.
Medrobotics Corporation operates in the following industries: Biotechnology, Hardware, Health Care, Robotics.
Medrobotics Corporation has approximately 26 employees.
Medrobotics Corporation has completed 14 funding rounds, raising a total of $206.50M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Medrobotics Corporation include EndoQuest Robotics, Custos Robotics ApS, MMI - Medical Microinstruments, Inc., Robotic Innovations, Exaptec. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Medrobotics Corporation and EndoQuest Robotics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Medrobotics Corporation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes